Skip to main content

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

TRDA holding history

Entrada Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TRDA overviewAll 13F holders of TRDAFull Q2 2026 holdings

Shares (Q2 2026)
32,397
Value
$238.4K
% of portfolio
<0.1%
Quarters held
4
Since Q3 2025
Holdings of TRDA by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202632,397$238.4K<0.1%−46,650−59.0%ReducedHolders
Q1 202679,047$997.6K<0.1%+12,169+18.2%AddedHolders
Q4 202566,878$687.5K<0.1%−4,670−6.5%ReducedHolders
Q3 202571,548$415.0K<0.1%+71,548NewHolders